Article | February 3, 2025

How Oral GLP-1 Therapies Are Revolutionizing Obesity Treatment

Ready-To-Use GLP-1

In recent years, rising incidence and severity of obesity has amplified therapeutic need for this healthcare segment globally, creating healthcare and economic crises. Its increasing prevalence and association with numerous diseases, e.g., metabolic disorders like type 2 diabetes, require effective pharmacological treatments and patient lifestyle changes to overcome.

In this interview, Dr. Srinivasan Shanmugam of Adare Pharma Solutions discusses the challenges, considerations, and game-changing impact of GLP-1 analogs, particularly in oral formulations, for obesity therapy.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader